{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:40:26Z","timestamp":1730108426646,"version":"3.28.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Int"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s13340-024-00756-z","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T18:02:12Z","timestamp":1726855332000},"page":"855-860","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypovascular insulinoma with reduced microvessel density on histopathology: a case report"],"prefix":"10.1007","volume":"15","author":[{"given":"Risako","family":"Imai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayu","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayako","family":"Ozeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sodai","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Takao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuo","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Horikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Kanayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiko","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"issue":"5","key":"756_CR1","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/s10147-022-02130-y","volume":"27","author":"T Masui","year":"2022","unstructured":"Masui T, Ito T, Komoto I, Kojima S, Kasai Y, et al. Nationwide registry for patients with neuroendocrine neoplasm of pancreas, gastrointestinal tract, lungs, bronchi, or thymus in Japan. Int J Clin Oncol. 2022;27(5):840\u20139.","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"756_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3748\/wjg.v19.i6.829","volume":"19","author":"T Okabayashi","year":"2013","unstructured":"Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, et al. Diagnosis and management of insulinoma. World J Gastroenterol. 2013;19(6):829\u201337.","journal-title":"World J Gastroenterol"},{"key":"756_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1148\/radiol.12112512","volume":"216","author":"DV Sahani","year":"2013","unstructured":"Sahani DV, Bonaffini PA, Castillo CF, Blake MA. Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. Radiology. 2013;216:38\u201361.","journal-title":"Radiology"},{"issue":"1","key":"756_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57\u201370.","journal-title":"Cell"},{"issue":"12","key":"756_CR5","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.trecan.2016.10.016","volume":"2","author":"L Schito","year":"2016","unstructured":"Schito L, Semenza GL. Hypoxia-inducible factors: master regulators of cancer progression. Trends in Cancer. 2016;2(12):758\u201370.","journal-title":"Trends in Cancer"},{"issue":"40","key":"756_CR6","doi-asserted-by":"publisher","first-page":"65837","DOI":"10.18632\/oncotarget.11670","volume":"7","author":"CJ Yeom","year":"2016","unstructured":"Yeom CJ, Zeng L, Goto Y, Morinibu A, Zhu Y, et al. LY6E: a conductor of malignant tumor growth through modulation of the PTEN\/PI3K\/Akt\/HIF-1 axis. Oncotarget. 2016;7(40):65837\u201348.","journal-title":"Oncotarget"},{"issue":"6C","key":"756_CR7","first-page":"4721","volume":"23","author":"T Shibaji","year":"2003","unstructured":"Shibaji T, Nagao M, Ikeda N, Kanehiro H, Hisanaga M, et al. Prognostic significance of HIF-1 alpha overexpression in human pancreatic cancer. Anticancer Res. 2003;23(6C):4721\u20137.","journal-title":"Anticancer Res"},{"issue":"3","key":"756_CR8","first-page":"102","volume":"36","author":"H Zhan","year":"2013","unstructured":"Zhan H, Liang H, Liu X, Deng J, Wang B, et al. Expression of Rac1, HIF-1\u03b1, and VEGF in gastric carcinoma: correlation with angiogenesis and prognosis. Onkologie. 2013;36(3):102\u20137.","journal-title":"Onkologie"},{"key":"756_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/sj.bjc.6602245","volume":"92","author":"A Couvelard","year":"2005","unstructured":"Couvelard A, O\u2019Toole D, Turley H, Leek R, Sauvanet A, et al. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. Br J Cancer. 2005;92:94\u2013101.","journal-title":"Br J Cancer"},{"key":"756_CR10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s11604-017-0627-x","volume":"35","author":"F Toshima","year":"2017","unstructured":"Toshima F, Inoue D, Komori T, Yoshida K, Yoneda N, et al. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors? Jpn J Radiol. 2017;35:242\u201353.","journal-title":"Jpn J Radiol"},{"key":"756_CR11","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1007\/s00330-014-3317-4","volume":"24","author":"Y Luo","year":"2014","unstructured":"Luo Y, Dong Z, Chen J, Chan T, Lin Y, et al. Pancreatic neuroendocrine tumors: correlation between MSCT features and pathological classification. Eur Radiol. 2014;24:2945\u201352.","journal-title":"Eur Radiol"},{"key":"756_CR12","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/jmri.22541","volume":"33","author":"Y Wang","year":"2011","unstructured":"Wang Y, Chen ZE, Yaghmai V, Nikolaidis P, McCarthy RJ, et al. Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics. J Magn Reson Imaging. 2011;33:1071\u20139.","journal-title":"J Magn Reson Imaging"},{"issue":"10","key":"756_CR13","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1007\/s00330-016-4216-7","volume":"26","author":"L Zhu","year":"2016","unstructured":"Zhu L, Xue HD, Sun H, Wang X, He YL, et al. Isoattenuating insulinomas at biphasic contrast-enhanced CT: frequency, clinicopathologic features and perfusion characteristics. Eur Radiol. 2016;26(10):3697\u2013705.","journal-title":"Eur Radiol"},{"key":"756_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1148\/radiol.2501080291","volume":"250","author":"G d'Assignies","year":"2009","unstructured":"d\u2019Assignies G, Couvelard A, Bahrami S, Vullierme MP, Hammel P, et al. Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology. 2009;250:407\u201316.","journal-title":"Radiology"},{"key":"756_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejrad.2018.04.006","volume":"110","author":"G Karmazanovsky","year":"2019","unstructured":"Karmazanovsky G, Belousova E, Schima W, Glotov A, Kalinin D, et al. Nonhypervascular pancreatic neuroendocrine tumors: spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma. Eur J Radiol. 2019;110:66\u201373.","journal-title":"Eur J Radiol"},{"issue":"4","key":"756_CR16","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.surg.2022.06.017","volume":"172","author":"A Battistella","year":"2022","unstructured":"Battistella A, Partelli S, Andreasi V, Marinoni I, Palumbo D, et al. Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). Surgery. 2022;172(4):1236\u201344.","journal-title":"Surgery"},{"issue":"4","key":"756_CR17","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0016-5085(03)01198-3","volume":"125","author":"AM Marion-Audibert","year":"2003","unstructured":"Marion-Audibert AM, Barel C, Gouysse G, Dumortier J, Pilleul F, et al. Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroenterology. 2003;125(4):1094\u2013104.","journal-title":"Gastroenterology"},{"issue":"11","key":"756_CR18","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3748\/wjg.v13.i11.1680","volume":"13","author":"J Ma","year":"2007","unstructured":"Ma J, Zhang L, Ru GO, Zhao ZS, Xu WJ. Upregulation of hypoxia inducible factor 1alpha mRNA is associated with elevated vascular endothelial growth factor expression and excessive angiogenesis and predicts a poor prognosis in gastric carcinoma. World J Gastroenterol. 2007;13(11):1680\u20136.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"756_CR19","doi-asserted-by":"publisher","first-page":"e0146823","DOI":"10.1371\/journal.pone.0146823","volume":"11","author":"H Nalwoga","year":"2016","unstructured":"Nalwoga H, Ahmed L, Arnes JB, Wabinga H, Akslen LA. Strong expression of hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) is associated with Axl expression and features of aggressive tumors in african breast cancer. PLoS ONE. 2016;11(1):e0146823.","journal-title":"PLoS ONE"},{"key":"756_CR20","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.2169\/internalmedicine.1173-18","volume":"57","author":"T Sugawa","year":"2017","unstructured":"Sugawa T, Murakami T, Yabe D, Kashima R, Tatsumi M, et al. Hypoglycemia unawareness in insulinoma revealed with flash glucose monitoring systems. Intern Med. 2017;57:3407\u201312.","journal-title":"Intern Med"},{"issue":"1","key":"756_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1507\/endocrj.53.79","volume":"53","author":"H Kishikawa","year":"2006","unstructured":"Kishikawa H, Okada Y, Hirose A, Tanikawa T, Kanda K, et al. Successful treatment of insulinoma by a single daily dose of octreotide in two elderly female patients. Endocr J. 2006;53(1):79\u201385.","journal-title":"Endocr J"},{"key":"756_CR22","doi-asserted-by":"publisher","first-page":"15014","DOI":"10.1038\/s41598-021-94595-6","volume":"11","author":"T Murakami","year":"2021","unstructured":"Murakami T, Fujimoto H, Hamamatsu K, Yamauchi Y, Kodama Y, et al. Distinctive detection of insulinoma using [18F]FB(ePEG12)12-exendin-4 PET\/CT. Sci Rep. 2021;11:15014.","journal-title":"Sci Rep"},{"issue":"3","key":"756_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/jdi.13730","volume":"13","author":"T Murakami","year":"2022","unstructured":"Murakami T, Yabe D, Inagaki N. Unmet needs in current clinical practice for insulinoma: Lessons from nationwide studies in Japan. J Diabetes Investig. 2022;13(3):429\u201331.","journal-title":"J Diabetes Investig"},{"key":"756_CR24","doi-asserted-by":"publisher","first-page":"714348","DOI":"10.3389\/fendo.2021.714348","volume":"12","author":"T Murakami","year":"2021","unstructured":"Murakami T, Fujimoto H, Inagaki N. Non-invasive beta-cell imaging: visualization, quantification, and beyond. Front Endocrinol. 2021;12:714348.","journal-title":"Front Endocrinol"}],"container-title":["Diabetology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13340-024-00756-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13340-024-00756-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13340-024-00756-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T08:52:45Z","timestamp":1730105565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13340-024-00756-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["756"],"URL":"https:\/\/doi.org\/10.1007\/s13340-024-00756-z","relation":{},"ISSN":["2190-1678","2190-1686"],"issn-type":[{"type":"print","value":"2190-1678"},{"type":"electronic","value":"2190-1686"}],"subject":[],"published":{"date-parts":[[2024,9,20]]},"assertion":[{"value":"6 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DY has received consulting\/lecture fees from Novo Nordisk Pharma Ltd., Nippon Boehringer Ingelheim, Eli Lilly Japan K.K., and Kyowa Kirin Co., Ltd. DY also received grants from Arkray Inc., Novo Nordisk Pharma Ltd., Nippon Boehringer Ingelheim, Taisho Pharmaceutical Co. Ltd., and Terumo Corporation. YH has received lecture fees from Sumitomo Pharma Co. Ltd. RI, MS, TK, SO, SK, YL, YT, KT, MM, TH, TM, TK, TK, and TM declare that they have no conflict of interest. All authors declare that they have no competing interests relevant to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Formal ethics approval was waived for this paper by the ethics committee of Gifu University Graduate School of Medicine due to its being a case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal research"}}]}}